J&J, Novartis and Takeda in talks for Brazil's Hypermarcas, sources say

Banco Bradesco

24/04/2017 15:32

By Tatiana Bautzer and Guillermo Parra-Bernal 
    SAO PAULO, April 24 (Reuters) - Johnson & Johnson  JNJ.N , 
Novartis AG  NOVN.S  and Takeda Pharmaceutical Co Ltd  4502.T  
are in talks with the controlling bloc of Brazilian drugmaker 
Hypermarcas SA  HYPE3.SA  for a buyout, two people with 
knowledge of the matter said on Monday.  
    Families owning investment vehicles Igarapava Participações 
SA and Maiorem SA de CV, which hold a combined 34 percent of 
Hypermarcas, hired the investment banking units of Banco 
Bradesco SA  BBDC4.SA  and Credit Suisse Group AG  CSGN.S  to 
advise on a sale, said the sources, who requested anonymity 
because the talks are private. 
 
 (Reporting by Tatiana Bautzer; Additional reporting by Bruno 
Federowski; Editing by Chizu Nomiyama) 
 ((tatiana.bautzer@tr.com; Tel: +55-11-5644-7756; Mob: 
+55-119-4210-4173; Reuters Messaging: 
tatiana.bautzer.thomsonreuters.com@reuters.net)) 
 
Keywords: HYPERMARCAS M&A/